Predictors of adherence to adjuvant endocrine therapy (ET) for early breast cancer (BC) in a prospective clinic-based cohort

被引：0
|
作者：
Smith, Karen L.
Yeruva, Sri L. H.
Blackford, Amanda
Huang, Chiung-Yu
Westbrook, Kelly E.
Harding, Brennen A.
Smith, Ar'Lena
Fetting, John
Wolff, Antonio C.
Jelovac, Danijela
Miller, Robert S.
Connolly, Roisin
Armstrong, Deborah
Nunes, Raquel
Visvanathan, Kala
Stearns, Vered
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Howard Univ, Sch Med, Washington, DC 20059 USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] Amer Soc Clin Oncol, Alexandria, VA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-12-02
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Women's experience and knowledge of adjuvant endocrine therapy (AET) for early breast cancer (BC):: A European survey
    Wengstrom, Yvonne
    Costa, Alberto
    Koedam, Jan
    Georgiou, Vasoulla
    ANNALS OF ONCOLOGY, 2006, 17 : 99 - 99
  • [42] Impact of adjuvant endocrine therapy (ET) omission in ER plus breast cancer (BC) treated with neoadjuvant chemotherapy (NAC)
    Choong, Grace M.
    Boughey, Judy C.
    Hoskin, Tanya L.
    Day, Courtney N.
    Goetz, Matthew P.
    CANCER RESEARCH, 2023, 83 (05)
  • [43] Serum assessment of non-adherence to adjuvant endocrine therapy (ET) among premenopausal patients in the prospective multicenter CANTO cohort
    Pistilli, B.
    Paci, A.
    Michiels, S.
    Ferreira, A.
    Poinsignon, V.
    Cottu, P. H.
    Lerebours, F.
    Coutant, C.
    Lesur, A.
    Tredan, O.
    Soulie, P.
    Vanlemmens, L.
    Jouannaud, C.
    Levy, C.
    Everhard, S.
    Arveux, P.
    Partridge, A. H.
    Delaloge, S.
    Andre, F.
    Vaz-Luis, I.
    ANNALS OF ONCOLOGY, 2018, 29
  • [44] Good adherence to adjuvant endocrine therapy in early breast cancer a population-based study based on the Swedish prescribed Drug Register
    Lundgren, Christine
    Lindman, Henrik
    Rolander, Bo
    Ekholm, Maria
    ACTA ONCOLOGICA, 2018, 57 (07) : 935 - 940
  • [45] Predictive biomarkers of endocrine therapy (ET) for stage IV breast cancer (BC)
    Shimizu, C.
    Hashimoto, K.
    Tsuda, H.
    Kobayashi, T.
    Saji, S.
    Shigekawa, T.
    Osaki, A.
    Aogi, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] Trajectories of adherence to adjuvant endocrine therapy for 5 years in women with breast cancer
    Memoli, V.
    Lailler, G.
    Le-Bihan, C.
    Bendiane, M. K.
    Lauzier, S.
    Mancini, J.
    Bousquet, P. J.
    Bouhnik, A. D.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2020, 30
  • [47] Influence of Patient and Treatment Factors on Adherence to Adjuvant Endocrine Therapy in Breast Cancer
    Bender, Catherine M.
    Gentry, Amanda L.
    Brufsky, Adam M.
    Casillo, Frances E.
    Cohen, Susan M.
    Dailey, Meredith M.
    Donovan, Heidi S.
    Dunbar-Jacob, Jacqueline
    Jankowitz, Rachel C.
    Rosenzweig, Margaret Q.
    Sherwood, Paula R.
    Sereika, Susan M.
    ONCOLOGY NURSING FORUM, 2014, 41 (03) : 274 - 285
  • [48] Supporting women with adherence to adjuvant endocrine therapy following breast cancer (SWEET)
    Watson, Eila
    Wells, Mary
    Horne, Robert
    McGeagh, Lucy
    Brett, Jo
    Jones, Annie
    Clarke, Amy
    Brown, Morven
    Mccue, Patricia
    Sharp, Linda
    BREAST CANCER RESEARCH, 2021, 23
  • [49] Factors Influencing Adherence to Adjuvant Endocrine Therapy After Breast Cancer Surgery
    Johnsson, Aina
    von Wachenfeldt, Anna
    CANCER REPORTS, 2024, 7 (08)
  • [50] Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer
    Lambert, Leah K.
    Balneaves, Lynda G.
    Howard, A. Fuchsia
    Chia, Stephen L. K.
    Gotay, Carolyn C.
    CURRENT ONCOLOGY, 2021, 28 (02) : 1472 - 1482
12345